Sugi Predict

Sugi Predict / Compounds / SCHEMBL6070239

SCHEMBL6070239

SCHEMBL6070239

CCOC(=O)C(C=O)C(C)=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.44
▸ LMNA P02545 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ GLO1 Q04760 1/20 0.39
▸ ALOX15 P16050 1/20 0.37
▸ MGAM O43451 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ SI P14410 1/20 0.37
▸ MGAM2 Q2M2H8 1/20 0.37
▸ SOAT1 P35610 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ HCAR2 Q8TDS4 1/20 0.35
▸ TRPA1 O75762 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ MAPT P10636 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ PIN1 Q13526 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10275655 0.88 ALDH1A1 (0.46) ALDH1A1LMNAHSD17B10GLO1ALOX15
SCHEMBL27326651 0.83 HCAR2 (0.39) ALDH1A1LMNAHSD17B10HCAR2HPGD
SCHEMBL15046951 0.80 ALDH1A1 (0.42) ALDH1A1LMNAHSD17B10GLO1ALOX15
SCHEMBL15474317 0.80 ALDH1A1 (0.39) ALDH1A1LMNAHSD17B10GLO1ALOX15
SCHEMBL10467804 0.77 ALDH1A1 (0.39) ALDH1A1LMNAHSD17B10GLO1ALOX15
SCHEMBL28116044 0.77 ALDH1A1 (0.39) ALDH1A1LMNAHSD17B10GLO1ALOX15
SCHEMBL11461030 0.77 ALDH1A1 (0.39) ALDH1A1LMNAHSD17B10GLO1ALOX15
SCHEMBL524836 0.76 — —
SCHEMBL377021 0.76 SMN1; SMN2 (0.39) ALDH1A1HCAR2SMN1; SMN2
Hydrochloric Acid SCHEMBL15561631 0.74 ALDH1A1 (0.42) ALDH1A1LMNAHSD17B10GLO1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 — — US disclosed
CN-104203929-A A new process for preparation of 4-methyloxazole-5-carboxylic ester DSM IP ASSETS BV 2014-12-10 — — CN disclosed
US-7087634-B2 Cyclic AMP-specific phosphodiesterase inhibitors ICOS CORPORATION (US) 2006-08-08 — — US disclosed
US-20030236412-A1 Cyclic AMP-specific phosphodiesterase inhibitors ICOS CORPORATION 2003-12-25 — — US disclosed
US-6569885-B1 Such as 1-(4-bromophenyl)-3,5-dimethyl-1H-pyrazole-4-carboxylic acid ethyl ester; side effect reduction; for treatment of central nervous system disorders ICOS CORPORATION 2003-05-27 — — US disclosed
EP-1248781-A1 PYRAZOLE CYCLIC AMP-SPECIFIC PDE INHIBITORS ICOS CORPORATION (US) 2002-10-16 — — EP disclosed
WO-2001046172-A1 PYRAZOLE CYCLIC AMP-SPECIFIC PDE INHIBITORS ICOS CORPORATION (US) 2001-06-28 — — WO disclosed
CN-1043704-A Cyclic amide derivative and weedicide thereof KUMIAI CHEMICAL INDUSTRY CO (JP) 1990-07-11 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030236412-A1 Cyclic AMP-specific phosphodiesterase inhibitors PDE4A, PDE4B, PDE7A ALDH1A1 1208/4885LMNA 4611/4885HSD17B10 1965/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.